Interprotein Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Interprotein Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10865
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interprotein Corp (Interprotein) is a drug development company that develops active modulators for protein-protein interaction (PPI) targets. The company offers products such as IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E and CD94 inhibitor, KIR and HLA-C inhibitor, gp130 inhibitor and RUNX1 and CBFß inhibitor. Its IL-6 inhibitor is used in the treatment of Castleman’s disease, rheumatoid arthritis and juvenile idiopathic arthritis, cachexia, and inflammatory and autoimmune diseases. The company operates through its laboratory located in Kanagawa, Japan. Interprotein is headquartered in Osaka City, Japan.

Interprotein Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Interprotein Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Interprotein Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Interprotein Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Interprotein Enters into R&D Agreement with A.I. Squared 10
Ipsen Enters into Research Agreement with Interprotein 11
Interprotein Enters Into Agreement With Takeda Pharma For PPI Inhibitors 12
RaQualia Pharma Enters Into Research Agreement With Interprotein For PPI Inhibitor 13
Interprotein Corp – Key Competitors 14
Interprotein Corp – Key Employees 15
Interprotein Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Feb 08, 2018: Interprotein: Program copyright registration of “the system for predicting pharmacological activity of compounds by AI (deep learning)” 17
Product News 18
May 16, 2018: AI-guided INTENDD, Interprotein’s AI drug discovery platform based on deep learning of binding structures of small molecules and target proteins, is transitioning into a practical stage 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Interprotein Corp, Pharmaceuticals & Healthcare, Key Facts 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Interprotein Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Interprotein Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Interprotein Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Interprotein Enters into R&D Agreement with A.I. Squared 10
Ipsen Enters into Research Agreement with Interprotein 11
Interprotein Enters Into Agreement With Takeda Pharma For PPI Inhibitors 12
RaQualia Pharma Enters Into Research Agreement With Interprotein For PPI Inhibitor 13
Interprotein Corp, Key Competitors 14
Interprotein Corp, Key Employees 15
Interprotein Corp, Other Locations 16

List of Figures
Interprotein Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Interprotein Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Interprotein Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Interprotein Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BASF SE (BAS):製薬・医療:M&Aディール及び事業提携情報
    Summary BASF SE (BASF) is a chemical company, which carries out the research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additive …
  • HPQ Silicon Resources Inc (HPQ):企業の財務・戦略的SWOT分析
    Summary HPQ Silicon Resources Inc (HPQ Silicon), formerly Uragold Bay Resources, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, production and development of silicon, gold and quartz properties, among others. It holds interests in The B …
  • CNOOC Ltd (883)-石油・ガス分野:企業M&A・提携分析
    Summary CNOOC Limited (CNOOC) is an upstream oil and gas exploration and production company. It engages in exploration, development, production and sale of crude oil and natural gas. In offshore China, the company engages in oil and natural gas exploration, development and production in Bohai, Weste …
  • Herman Miller Inc (MLHR):企業の財務・戦略的SWOT分析
    Herman Miller Inc (MLHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The TJX Companies, Inc.:企業の戦略・SWOT・財務情報
    The TJX Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The TJX Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Renewable Energy Group, Inc.:企業の戦略・SWOT・財務分析
    Renewable Energy Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Renewable Energy Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sinopharm Group Co Limited:企業の戦略・SWOT・財務分析
    Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Synchrony Financial:企業の戦略・SWOT・財務情報
    Synchrony Financial - Strategy, SWOT and Corporate Finance Report Summary Synchrony Financial - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • HCL Technologies Limited:企業の戦略・SWOT・財務分析
    HCL Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary HCL Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PT Medco Energi Internasional Tbk (MEDC):電力:M&Aディール及び事業提携情報
    Summary PT Medco Energi Internasional Tbk (MedcoEnergi), a subsidiary of Encore Energy Pte. Ltd., is an integrated energy company. It explores for and develops oil and gas fields. The company provides energy related services such as power production, engineering procurement and construction (EPC), o …
  • ONEOK Partners LP:企業の戦略的SWOT分析
    ONEOK Partners LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Moderna Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Moderna Therapeutics Inc (Moderna Therapeutics) is a developer of messenger RNA therapeutics. The company provides in vivo drug modality that produces human proteins or antibodies inside patient cells. Its pipeline includes various drug modalities such as prophylactic vaccines, therapeutic v …
  • Church & Dwight Co Inc:戦略・SWOT・企業財務分析
    Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report Summary Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Red River Valley Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Medikit Co Ltd (7749):企業の財務・戦略的SWOT分析
    Summary Medikit Co Ltd (Medikit) is a medical equipment provider that offers vascular devices. The company offers IV catheter, hemodialysis and intervention products. Its products include supercath Z3V, supercath 5 safety IV catheter, supercath AZ, supercath CLS, i-works, seiha, parent plus, parent …
  • PetroChina Co Ltd (857):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroChina Co Ltd (PetroChina) operates a subsidiary of China National Petroleum Corporation. It is an oil and gas company that explores for and develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical pro …
  • Foshan Electrical and Lighting Co Ltd (000541):企業の財務・戦略的SWOT分析
    Summary Foshan Electrical and Lighting Co Ltd (Foshan Lighting) is a manufacturer and marketer of lighting products and electrical equipment. The company's products include home lighting, LED lighting products, traditional lighting and fixtures, vehicle lighting products, and electrical supports. It …
  • HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rio Tinto:企業のM&A・事業提携・投資動向
    Rio Tinto - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rio Tinto Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Daihatsu Motor Co Ltd:企業の戦略・SWOT・財務情報
    Daihatsu Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daihatsu Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆